FMI
VRTX icon

Frec Markets Inc’s Vertex Pharmaceuticals VRTX Stock Holding History

Frec Markets Inc’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.38M Buy
2,778
+1,243
+81% +$551K 0.12% 140
2026
Q1 		$685K Buy
1,535
+218
+17% +$102K 0.12% 176
2025
Q4 		$597K Buy
+1,317
New +$568K 0.17% 108

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Frec Markets Inc's VRTX Position: Q2 2026 in Review

Frec Markets Inc increased its Vertex Pharmaceuticals (VRTX) stake by 81% in Q2 2026, buying an estimated $551K and bringing the position to 2,778 shares worth $1.38M. The position accounts for 0.12% of the portfolio, ranked #140.

Frec Markets Inc first reported a position in VRTX in Q4 2025 and has held it in 3 quarters since. 1,754 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.

  • Frec Markets Inc held 2,778 shares of Vertex Pharmaceuticals worth $1.38M as of Q2 2026.
  • Frec Markets Inc bought 1,243 Vertex Pharmaceuticals shares in Q2 2026, an estimated $551K.
  • Vertex Pharmaceuticals made up 0.12% of Frec Markets Inc's portfolio in Q2 2026, its #140 holding.
  • Frec Markets Inc first reported a position in Vertex Pharmaceuticals in Q4 2025 and has held it in 3 quarters since.
  • 1,754 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.

Based on Frec Markets Inc's 13F filing for Q2 2026, filed 13 Aug 2026.